Andrew James King - 29 Jul 2022 Form 4 Insider Report for CHINOOK THERAPEUTICS, INC.

Role
Chief Scientific Officer
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
29 Jul 2022
Net transactions value
$0
Form type
4
Filing time
02 Aug 2022, 16:50:10 UTC
Previous filing
13 Jul 2022
Next filing
05 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KDNY Restricted Stock Units Award $0 +10,000 $0.000000 10,000 29 Jul 2022 Common Stock 10,000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The RSUs vest as to one-third (1/3) of the total award on the first, second, and third anniversaries of the grant date, subject to the reporting person's continued service to the Issuer on each vesting date.
F3 These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.